click links below for full documents
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis - By A. Novotna, et al. Europ J Neurol 2011